Doximity, Inc. (DOCS) Stock Price & Analysis

Doximity, Inc. (DOCS) rose 0.74% to USD 20.45 as of June 10, 2026 at 00:48 UTC, according to Nexqual real-time market data.

DOCS last closed at USD 20.3; the session ranged USD 20.19–21.02 on volume of 3,133,709 shares. Market capitalization is $3.74B, with a 52-week range of USD 17.15–76.51 (NYQ). Source: Nexqual, June 10, 2026 at 00:48 UTC.

Key Statistics (as of June 10, 2026 at 00:48 UTC)

Technical Analysis (DOCS)

Nexqual's technical model rates DOCS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:48 UTC.

Analyst Ratings (DOCS)

Wall Street analysts rate DOCS "Buy" based on 20 analysts, with a mean price target of USD 25.15 (range USD 18–42), per Nexqual as of June 10, 2026 at 00:48 UTC.

Earnings (DOCS)

Recent Earnings History

Source: Nexqual, June 10, 2026 at 00:48 UTC.

Financials & Fundamentals (DOCS)

Source: Nexqual, June 10, 2026 at 00:48 UTC.

Financial Health Score (DOCS)

Nexqual rates Doximity, Inc.'s overall financial health "Strong" across five dimensions, as of June 10, 2026 at 00:48 UTC.

Ownership (DOCS)

Source: Nexqual, June 10, 2026 at 00:48 UTC.

Leadership (DOCS)

Doximity, Inc. is led by Jeffrey A. Tangney (age 52), Co-Founder, CEO & Chairperson, per Nexqual as of June 10, 2026 at 00:48 UTC.

Major Backers & Investors (DOCS)

Notable institutional backers of Doximity, Inc. include ClearBridge Investments, LLC, William Blair Investment Management, LLC, Baillie Gifford, according to Nexqual as of June 10, 2026 at 00:48 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, June 10, 2026 at 00:48 UTC.

From Doximity, Inc.'s Latest SEC 10-K Filing (filed 2026-05-19)

Key Strengths & Strategy (as disclosed to the SEC)

• The product is HIPAA-compliant for all users, with data encrypted in transit and at rest. 7 Table of Contents Clinical AI Suite for Hospitals and Health Systems Doximity's Clinical AI Suite brings together Ask, Scribe, and Dialer into a unified, AI-powered workflow that supports clinical communication, documentation, and fast, evidence-backed answers to clinical questions.
• Overview We are the leading physician-first tech company, with over 3 million registered members 1 as of March 31, 2026.
• Once verified, members gain access to our network, newsfeed, and—depending on their credentials—our Clinical AI Suite, including Dialer, our voice and video telehealth product; Scribe, our ambient AI that listens during patient visits and generates structured notes; and Ask (formerly DoxGPT), which provides evidence-based answers to clinical questions, including drug information.
• For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act and the California Privacy Act.

Partnerships

• Specifically, we compete for medical professionals as platform members, and for pharmaceutical and health system companies as customers for our Marketing, Hiring, and Workflow Solutions. • Competing for members: We compete with large technology companies that have developed online networking and collaboration tools such as LinkedIn, Facebook, Google, and X, in addition to smaller, emerging companies.
• Patients can search for the right doctor or hospital for their needs through our collaboration with the Doctor Finder tool of U.S.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:48 UTC. This page is informational and not investment advice.